Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

As Drug Development Costs Skyrocket, AI Offers Some Hope

Posted on November 20th, 2017 by in Pharma R&D

Last year, researchers from the Tufts Center for the Study of Drug Development published a paper in the Journal of Health Economics that provided an assessment of the current cost for pharmaceutical companies to discover and develop new drugs and biologics. (more…)

Myelo Therapeutics Takes on Unmet Needs in Cancer

Posted on November 17th, 2017 by in Pharma R&D

Many pharmaceutical and biotechnology start-ups have been founded for the purpose of taking on unmet needs. It has often been difficult for the larger, more established pharma companies to focus on these narrower problems, so the leaner, scrappier start-ups are putting their passion and brainpower to the challenges that have yet to be tackled. (more…)

Drug Companies Collaborate to Take on the Opioid Crisis

Posted on November 8th, 2017 by in Pharma R&D

hands-1903104_640

The opioid crisis in the US is now responsible for taking more American lives each year than car crashes. (more…)

Advances in Gene & Cell Therapy

Posted on November 6th, 2017 by in Pharma R&D

I would like to applaud the recent news about the Advisory Panel to the USA FDA’s unanimous (16-0) recommendation for allowing to further develop therapy by Spark Therapeutics Inc. (more…)

  1. 1
  2. 4
  3. 5
  4. 6
  5. 7
  6. 8
  7. 11